Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Metabolic syndrome: obesity, hypertension, diabetes and now also inflammation

12.09.2005


Metabolic syndrome is a combination of several individual metabolic problems that lead to high risk of atherosclerosis and heart problems. The disease has become a serious global problem in the last two decades with as much as 47 millions of cases in US and 25 million in Europe, and further understanding of its origin and mechanism is urgent. To that aim, in an article just published online in the International Journal of Obesity, a group of Portuguese scientists reports that patients suffering from severe metabolic syndrome show high levels of Protein-C reactive (CRP), an inflammatory marker, a result that suggests a role for inflammation in the disease. Additionally, it was also found that central obesity (found around the abdomen/organs) and high blood pressure, two of the metabolic problems associated with the syndrome, were directly associated with the increase in CRP levels making them into preferential targets for both therapy and prevention.



Metabolic syndrome was first described 80 years ago as a cluster of three or more specific health conditions in an individual that leads to high risk of cardiovascular disease. The health conditions associated with the syndrome (also called syndrome’s components) include obesity (especially central obesity, which is found around the viscera/abdomen), type 2 diabetes, insulin resistance, abnormal amounts of fat in the blood and high blood pressure (hypertension).

For most patients the origin of the syndrome seems to be related with poor nutrition, lack of physical activity and subsequent increase in body weight, and the raise in metabolic syndrome numbers is believed to be associated with the global epidemic of obesity and diabetes. The disease spreading has led to serious health concerns, especially in relation to the increased risk of cardiovascular problems observed in patients, and consequently to the realisation that better preventive and therapeutic measures were necessary.


CRP is a protein produced and released by the liver during inflammation that has recently been associated with increased risk for hypertension and heart disease. The amount of CRP produced in the body varies from person to person and is affected by the individual’s genetic makeup and lifestyle. Higher CRP levels tend to be found in individuals who smoke, have high blood pressure, are overweight and don’t exercise, whereas lean, athletic individuals tend to have lower CRP levels.

High CRP levels (although within the normal range/within the basal level) have also been associated with metabolic syndrome and, furthermore, with several of the syndrome’s individual components what led Ana-Cristina Santos, Henrique Barros and colleagues from the Department of Hygiene and Epidemiology, University of Porto Medical School, Portugal to decide to further investigate the relationship between the levels of this protein and metabolic syndrome.

The group of scientists studied 1022 individuals aged between 18 to 92 and found that, as previously proposed by others, metabolic syndrome patients present higher CRP levels than normal, healthy individuals. Additionally, it was observed that individuals with a higher number of syndrome’s components (and consequently a more severe disease/syndrome) would show higher CRP levels. These results support the view that inflammation is an important part of metabolic syndrome and led Santos, Barros and colleagues to propose that anti-inflammatory drugs, following further research, might be included in disease therapy.

Furthermore, the finding that central obesity and hypertension are the main syndrome’s components associated with high CRP levels further highlights the need to control these two metabolic problems and their importance as main targets for prevention and therapy measures.

Piece researched and written by: Catarina Amorim (catarina.amorim@linacre.ox.ac.uk)

Catarina Amorim | alfa
Further information:
http://www.nature.com/ijo/journal/vaop/ncurrent/abs/0803035a.html

More articles from Health and Medicine:

nachricht On track to heal leukaemia
18.01.2017 | Universitätsspital Bern

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Explaining how 2-D materials break at the atomic level

18.01.2017 | Materials Sciences

Data analysis optimizes cyber-physical systems in telecommunications and building automation

18.01.2017 | Information Technology

Reducing household waste with less energy

18.01.2017 | Ecology, The Environment and Conservation

VideoLinks
B2B-VideoLinks
More VideoLinks >>>